Vaishali Pharma [VAISHALI] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
Vaishali Pharma
NSE
Loading...
Divi's Laboratories
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Vaishali Pharma wins in 4 metrics, Divi's Laboratories wins in 14 metrics, with 0 ties. Divi's Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Vaishali Pharma | Divi's Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 214.50 | 68.71 | Divi's Laboratories |
| Price-to-Book Ratio | 2.57 | 10.59 | Vaishali Pharma |
| Debt-to-Equity Ratio | 18.98 | 0.03 | Divi's Laboratories |
| PEG Ratio | -2.41 | 106.11 | Vaishali Pharma |
| EV/EBITDA | 1,971.56 | 50.08 | Divi's Laboratories |
| Profit Margin (TTM) | 0.83% | 23.89% | Divi's Laboratories |
| Operating Margin (TTM) | -18.32% | 25.60% | Divi's Laboratories |
| EBITDA Margin (TTM) | N/A | 25.60% | N/A |
| Return on Equity | 1.52% | 14.64% | Divi's Laboratories |
| Return on Assets (TTM) | -0.26% | 12.94% | Divi's Laboratories |
| Free Cash Flow (TTM) | $6.96M | $2.15B | Divi's Laboratories |
| Dividend Yield | N/A | 0.91% | N/A |
| 1-Year Return | -24.68% | 22.45% | Divi's Laboratories |
| Price-to-Sales Ratio (TTM) | 1.65 | 16.43 | Vaishali Pharma |
| Enterprise Value | $1.77B | $1,534.88B | Divi's Laboratories |
| EV/Revenue Ratio | 1.79 | 15.90 | Vaishali Pharma |
| Gross Profit Margin (TTM) | 14.97% | 60.33% | Divi's Laboratories |
| Revenue per Share (TTM) | $7 | $363 | Divi's Laboratories |
| Earnings per Share (Diluted) | $-1.55 | $86.94 | Divi's Laboratories |
| Beta (Stock Volatility) | 0.35 | 0.27 | Divi's Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vaishali Pharma vs Divi's Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vaishali Pharma | 0.65% | -2.91% | -2.45% | 2.32% | -22.26% | -30.81% |
| Divi's Laboratories | 1.31% | -7.03% | -14.75% | -0.77% | -0.41% | -2.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vaishali Pharma | -24.68% | 41.72% | 192.18% | 191.49% | 191.49% | 191.49% |
| Divi's Laboratories | 22.45% | 58.73% | 91.42% | 441.88% | 1,482.26% | 9,037.19% |
Performance & Financial Health Analysis: Vaishali Pharma vs Divi's Laboratories
| Metric | VAISHALI | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.64B | ₹1.59T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 391,275 | 478,417 |
| 90 Day Avg. Volume | 566,064 | 354,239 |
| Last Close | ₹12.41 | ₹5,992.00 |
| 52 Week Range | ₹10.30 - ₹24.91 | ₹4,615.55 - ₹7,071.50 |
| % from 52W High | -50.18% | -15.27% |
| All-Time High | ₹24.91 (Oct 14, 2024) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -50.18% | -15.27% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.14% |
| Quarterly Earnings Growth | 0.00% | 0.27% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.24% |
| Operating Margin (TTM) | -0.18% | 0.26% |
| Return on Equity (TTM) | 0.02% | 0.15% |
| Debt to Equity (MRQ) | 18.98 | 0.03 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹4.79 | ₹563.87 |
| Cash per Share (MRQ) | ₹0.14 | ₹132.86 |
| Operating Cash Flow (TTM) | ₹-180,383,008 | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹-217,039,120 | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.91% |
| Last 12-Month Dividend | N/A | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Vaishali Pharma vs Divi's Laboratories
| Metric | VAISHALI | DIVISLAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 214.50 | 68.71 |
| Forward P/E | N/A | 106.11 |
| PEG Ratio | -2.41 | 106.11 |
| Price to Sales (TTM) | 1.65 | 16.43 |
| Price to Book (MRQ) | 2.57 | 10.59 |
| Market Capitalization | ||
| Market Capitalization | ₹1.64B | ₹1.59T |
| Enterprise Value | ₹1.77B | ₹1.53T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.79 | 15.90 |
| Enterprise to EBITDA | 1,971.56 | 50.08 |
| Risk & Other Metrics | ||
| Beta | 0.35 | 0.27 |
| Book Value per Share (MRQ) | ₹4.79 | ₹563.87 |
Financial Statements Comparison: Vaishali Pharma vs Divi's Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VAISHALI | DIVISLAB |
|---|---|---|
| Revenue/Sales | ₹279.14M | ₹24.10B |
| Cost of Goods Sold | ₹237.35M | ₹9.56B |
| Gross Profit | ₹41.79M | ₹14.54B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹12.44M | ₹6.17B |
| EBITDA | ₹24.35M | ₹8.48B |
| Pre-Tax Income | ₹19.28M | ₹7.33B |
| Income Tax | ₹4.85M | ₹1.88B |
| Net Income (Profit) | ₹14.43M | ₹5.45B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VAISHALI | DIVISLAB |
|---|---|---|
| Cash & Equivalents | ₹10.21M | ₹4.15B |
| Total Current Assets | ₹983.93M | ₹100.81B |
| Total Current Liabilities | ₹329.65M | ₹14.52B |
| Long-Term Debt | ₹30.20M | ₹20.00M |
| Total Shareholders Equity | ₹677.63M | ₹149.69B |
| Retained Earnings | N/A | ₹134.00B |
| Property, Plant & Equipment | ₹13.10M | ₹3.19B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VAISHALI | DIVISLAB |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VAISHALI | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 391,275 | 478,417 |
| Average Daily Volume (90 Day) | 566,064 | 354,239 |
| Shares Outstanding | 107.19M | 265.47M |
| Float Shares | 74.88M | 120.74M |
| % Held by Insiders | N/A | 0.52% |
| % Held by Institutions | N/A | 0.29% |
Dividend Analysis & Yield Comparison: Vaishali Pharma vs Divi's Laboratories
| Metric | VAISHALI | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹60.00 |
| Last 12-Month Dividend Yield | N/A | 0.91% |
| 3-Year Avg Annual Dividend | N/A | ₹50.00 |
| 3-Year Avg Dividend Yield | N/A | 0.70% |
| 3-Year Total Dividends | N/A | ₹150.00 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |